Table 2. Characteristics of patient cases.
| Patent sets | ||
|---|---|---|
| Characteristic | Set A | Set B |
| Number | ||
| Patients | 21 | 78 |
| Normal subjects | 8 | 5 |
| Age for patients only | ||
| Minimum | 55 | 22 |
| Maximum | 87 | 90 |
| Median | 73 | 71 |
| Gleason Score | ||
| 2-6 | 8 (38%) | 24 (31%) |
| 7 (3+4) | 3 (14%) | 19 (24%) |
| 7 (4+3) | 2 (10%) | 17 (22%) |
| 8-10 | 8 (38%) | 17 (22%) |
| Insufficient data | 0 (0%) | 1 (1%) |
| Stage | ||
| T1 | 5 (24%) | |
| T2 | 7 (33%) | 60 (77%) |
| T3 | 9 (43%) | 18 (23%) |
| Lymph Node Status | ||
| N0 | 29 (37%) | |
| N1 | 0 (37%) | |
| Insufficient data | 49 (63%) | |
The percentage in parenthesis represents the percent of patient cases (not including normal subjects) in each category.